GGrantIndex
Sort

23,748 grants matching melanoma

The regulation of melanocyte stem cells by Wnt signaling

$372,900
Mayumi Ito · New York University School Of Medicine · R01 · FY2018 · AR

The regulation of melanocyte stem cells by Wnt signaling

$372,900
Mayumi Ito · New York University School Of Medicine · R01 · FY2016 · AR

ENHANCED DEVELOPMENT OF THE XIPHOPHORUS MODEL SYSTEM

$372,884
Texas State University-San Marcos · R24 · FY2001 · RR

Improved therapy for p53wt melanoma by functionally restoring the CDKN2A pathway

$372,875
Ann Richmond · Vanderbilt University · R01 · FY2017 · CA

Improved therapy for p53wt melanoma by functionally restoring the CDKN2A pathway

$372,875
Ann Richmond · Vanderbilt University · R01 · FY2015 · CA

Improved therapy for p53wt melanoma by functionally restoring the CDKN2A pathway

$372,875
Ann Richmond · Vanderbilt University · R01 · FY2016 · CA

Improved therapy for p53wt melanoma by functionally restoring the CDKN2A pathway

$372,875
Ann Richmond · Vanderbilt University · R01 · FY2018 · CA

Project 2: Spatial Architecture of Tumor-Mediated Immunosuppression

$372,870
Garry P Nolan · Stanford University · U54 · FY2020 · CA

Highly-Integrated Ultrasmall and Bright Fluorescent Silica Particle Architectures

$372,821
Ulrich Wiesner · Sloan-Kettering Inst Can Research · U54 · FY2015 · CA

New Strategies for Treatment of NRAS Mutant Melanoma after Progression on Immune Checkpoint Inhibitors

$372,669
Ann Richmond · Vanderbilt University · R01 · FY2022 · CA

The regulation of melanocyte stem cells by Wnt signaling

$372,645
Mayumi Ito · New York University School Of Medicine · R01 · FY2014 · AR

Role of gangliosides in tumor progression

$372,530
Stephan Ladisch · Children'S Research Institute · R01 · FY2011 · CA

Cancer Biology in the Zebrafish

$372,487
Leonard I Zon · Boston Children'S Hospital · R01 · FY2010 · CA

Combining senescence-inducing and senolytic agents to improve melanoma therapy

$372,444
Anna E Vilgelm · Vanderbilt University · R37 · FY2019 · CA

Stress-activated signaling in prostate cancer

$372,345
George A Kulik · Wake Forest University Health Sciences · R01 · FY2012 · CA

Development and Pre-Clinical Validation of Quantitative Imaging of Cell State Kinetics (QuICK) for Functional Precision Oncology

$372,336
Thomas Andrew Zangle · University Of Utah · R01 · FY2024 · CA

Core 2: Biostatistics and Bioinformatics Core

$372,239
Hong Wang · University Of Pittsburgh At Pittsburgh · P50 · FY2025 · CA

DEVELOPMENT OF GENOMICS BASED PERSONALIZED CANCER IMMUNOTHERAPY

$372,200
Robert David Schreiber · Washington University · R01 · FY2019 · CA

Suppression of Melanoma Initiation and Progression by NM23-H1

$372,198
David M Kaetzel · University Of Maryland Baltimore · R01 · FY2015 · CA

UNIVERSITY OF COLORADO SOUTHWEST ONCOLOGY GROUP

$372,040
University Of Colorado Denver · U10 · FY2000 · CA

Suppression of Melanoma Initiation and Progression by NM23-H1

$371,942
David M Kaetzel · University Of Maryland Baltimore · R01 · FY2016 · CA

Cancer biology in the zebrafish

$371,851
Leonard I Zon · Boston Children'S Hospital · R01 · FY2015 · CA

Immune Evasion in Human Squamous Cell Carcinomas of the Skin

$371,851
Rachael Ann Clark · Brigham And Women'S Hospital · R01 · FY2012 · AR

Bioengineering approaches to map mechanotransduction in the living cell

$371,733
Ning Wang · University Of Illinois At Urbana-Champaign · R01 · FY2015 · GM

Macrophage-based ovarian cancer immunotherapy

$371,717
Fiona E Yull · Vanderbilt University · R01 · FY2017 · CA